The trimeric chaperone Skp sequesters outer-membrane proteins (OMPs) within a hydrophobic cage, thereby preventing their aggregation during transport across the periplasm in Gram-negative bacteria. Here, we studied the interaction between Escherichia coli Skp and five OMPs of varying size. Investigations of the kinetics of OMP folding revealed that higher Skp/OMP ratios are required to prevent the folding of 16-stranded OMPs compared with their 8-stranded counterparts. Ion mobility spectrometry-mass spectrometry (IMS-MS) data, computer modeling and molecular dynamics simulations provided evidence that 10-to 16-stranded OMPs are encapsulated within an expanded Skp substrate cage. For OMPs that cannot be fully accommodated in the expanded cavity, sequestration is achieved by binding of an additional Skp trimer. The results suggest a new mechanism for Skp chaperone activity involving the coordination of multiple copies of Skp in protecting a single substrate from aggregation. npg
a r t i c l e s β-barrel OMPs perform numerous and diverse essential functions in the outer membrane (OM) of Gram-negative bacteria. After their synthesis in the cytoplasm, OMPs are translocated across the inner membrane and then must traverse the periplasm before reaching the OM, where the β-barrel assembly machinery (BAM) complex folds them and inserts them into the membrane [1] [2] [3] [4] [5] . Whereas the periplasmic chaperones Skp and SurA are considered to be the major OMP chaperones in E. coli, a network of folding factors is involved in OMP assembly, including trigger factor and SecB in the cytoplasm, and FkpA and DegP in the periplasm 1, 6, 7 . Periplasmic chaperones act without an external energy source (unlike many of the Hsp chaperones 8 ) because the periplasm is devoid of ATP 5 , and they bind and release their substrates through mechanisms that are not well understood 7 .
The holdase chaperone Skp protects OMPs against misfolding and aggregation during their transit between the inner and outer membranes [9] [10] [11] . Skp has broad substrate specificity 12 , and its reported affinities for its substrates are in the low-nanomolar range 13, 14 . Skp functions as a homotrimer (referred to herein as Skp), which has a 'jellyfish'-like architecture 10, 11 (Fig. 1a) consisting of three α-helical 'legs' that extend 60 Å away from the 'body' domain, a nine-stranded β-barrel that mediates trimerization 10, 11 . The three subunits of Skp form a hydrophobic cavity inside which OMP clients are bound 9, 12, 15, 16 . Previous studies have suggested a 1:1 stoichiometry for all Skp-OMP complexes 13, 17, 18 . These 1:1 stoichiometries have been proposed on the basis of tryptophan fluorescence (Skp complexes formed with tOmpA (19 kDa) 13 , NalP (32 kDa) 13 , OmpG (33 kDa) 13 , OmpA (35 kDa) 13, 17 or BamA (89 kDa) 13 ); NMR (OmpX (16 kDa) and tOmpA (19 kDa) 15 ); and fluorescence correlation spectroscopy (OmpC (38 kDa) 18 ). The Skp hydrophobic cavity has been estimated to be able to accommodate folded proteins of ~25 kDa (ref. 10 ), but many OMPs known to interact with Skp are considerably larger (for example, the 22-stranded BtuB and the 26-stranded LptD are 66 kDa and 87 kDa, respectively) 12 . These findings raise fundamental questions about the structural alterations that must occur to allow Skp to accommodate its larger substrates.
To investigate the mechanism by which Skp sequesters OMPs of different sizes, we used kinetic studies of OMP folding as well as ESI-IMS-MS analyses to examine the interactions of Skp with five diverse OMPs: (i) tOmpA, the eight-stranded transmembrane domain of OmpA 19 ; (ii) PagP, an eight-stranded acyltransferase enzyme 20 ; (iii) OmpT, a ten-stranded protease 21 ; (iv) OmpF, a 16-stranded trimeric porin 22 ; and (v) tBamA, the 16-stranded transmembrane domain of the BamA OMP insertase 23 (Fig. 1b-f and Supplementary Table 1 ). We found that the concentration of Skp required to prevent OMP insertion into 1,2-diundecanoyl-sn-glycero-3-phosphocholine (diC 11:0 PC) liposomes increased as the mass of client OMP increased, thus suggesting that the sequestration mechanism of Skp is altered for larger OMP clients. We used ESI-IMS-MS and computer modeling to examine the conformations of Skp-OMP complexes and provide evidence that the core of Skp expands to accommodate the larger OMPs, such that the largest clients require the formation of 2:1 Skp-OMP assemblies to completely sequester the polypeptide chain. Together, the results provide a new understanding of how Skp is able to bind, chaperone and release substrates that vary dramatically in size. These demands are met by expansion of the binding cage and/or formation of multivalent complexes.
RESULTS

Different Skp/OMP ratios are required to inhibit OMP folding
To assess the effects of Skp on the folding and membrane insertion of OMPs of varied size, we performed folding assays by dilution of unfolded protein stock solutions (in 8 M urea) 33-fold into buffer containing ~100-nm-diameter synthetic di C11:0 PC liposomes. We then measured the increase in tryptophan fluorescence associated with folding as a function of time. Maintaining a low protein concentration (0.4 µM) and a high lipid/protein ratio (3, 200 :1) enables folding to be monitored in a low final concentration of urea (0.24 M) without interference from aggregation. This approach enables real-time measurements of folding that are complementary to the SDS-PAGE-based studies that have been used to provide information about the fraction of folded (SDS-resistant) protein present at a particular time [24] [25] [26] .
To verify that the OMPs selected for study were able to fold into di C11:0 PC liposomes and/or interact with Skp under the experimental conditions used, we measured the fluorescence emission spectra of each OMP in 8 M or 0.24 M urea in the absence of liposomes (in the latter case with or without a two-fold molar excess of Skp). We then compared these spectra with those of membrane-inserted (folded) OMP obtained at the endpoint of the folding reaction ( Fig. 2a-d) .
The spectra of tOmpA, PagP, OmpF and tBamA folded into liposomes, as compared with the spectra of the unfolded proteins in 8 M urea, showed a characteristic blueshift in maximum wavelength (λ max ) and an increase in fluorescence intensity, thus indicating that a substantial fraction of all four OMPs folded successfully into the liposomes used. In the presence of Skp, the spectra of tOmpA, OmpF and tBamA showed decreases in λ max and/or intensity, as compared with the spectra of these OMPs in buffer alone, demonstrating that these unfolded OMPs interacted with Skp. For PagP, we observed no change in fluorescence in the presence of Skp, although these proteins do interact, as has been shown in previous work 27 .
We next investigated the effect of Skp on OMP folding kinetics. In the absence of Skp, the OMPs folded with either single-or doubleexponential kinetics ( Fig. 2a-d) , thereby allowing the folding rate constants (k 1 and k 2 ) to be extracted ( Fig. 2a-d and Supplementary  Table 2 ). To verify that the transients obtained reflected membrane insertion and folding, we performed assays in the absence of lipids ( Supplementary Fig. 1) . A folding transient was evident only for OmpT in the absence of lipid ( Supplementary Fig. 1e ), presumably reflecting folding of the large extracellular region of OmpT, which contains three tryptophan residues ( Supplementary Fig. 1f ). For all other OMPs, we observed no changes in fluorescence over time in the absence of lipid, thus indicating the formation of a stable soluble form, as previously reported 13, 27 . We then measured the folding kinetics of OMPs that had been preincubated with Skp at molar ratios ranging from 1:1 to 4:1 (chaperone/ client, with Skp concentrations in trimer equivalents; Online Methods) by adding the preformed complexes to diC 11:0 PC liposomes and monitoring OMP folding by fluorescence spectroscopy ( Fig. 2a-d and Supplementary  Fig. 2) . The results showed that at a substrate concentration of 0.4 µM, a two-fold molar excess of Skp was sufficient to prevent tOmpA and PagP from folding into liposomes ( Fig. 2a,b and Supplementary Fig. 2a,b) . We have previously shown that whereas incubation of Skp with PagP in a 2:1 ratio prevents OMP folding over a 2-h timescale, overnight incubation with liposomes allows OMP release and folding to equivalent yields as those in the absence of Skp 27 . For both of the eight-stranded OMPs, tOmpA and PagP, a 1:1 Skp/OMP ratio retarded folding, whereas a 2:1 ratio prevented folding over the timescale of the experiment. By contrast, preincubation of OmpF and tBamA with a two-fold excess of Skp decreased the folding rate but did not prevent folding (Fig. 2c,d and Supplementary  Fig. 2c,d) . However, preincubation with a four-fold excess of Skp inhibited folding of these larger proteins over the timescale of the experiment (Fig. 2c,d and Supplementary Fig. 2c,d) . Therefore, the results suggested that complete sequestration of larger OMP barrels requires the binding of more than one copy of Skp.
Stoichiometries of Skp-OMP assemblies studied by ESI-MS
To gain insights into the architectures of Skp-OMP assemblies, we used ESI-MS coupled with IMS to analyze different Skp-OMP complexes within multicomponent mixtures. We prepared Skp assemblies with tOmpA, PagP, OmpT, OmpF and tBamA and acquired mass spectra under instrumental conditions allowing noncovalent interactions to be retained in vacuo (termed noncovalent or 'native' MS) [28] [29] [30] (Online Methods) ( Fig. 3, Supplementary Fig. 3a-f and Supplementary Table 3 ). The results showed that all five Skp-OMP assemblies were sufficiently stable to survive the ESI process and to be transferred into the gas phase for analysis.
Several reports have suggested that Skp binds unfolded OMPs ranging from 16 to 89 kDa (8-16 β-strands in the native state) with a 1:1 stoichiometry 13, 15, 17, 18 . By contrast, the mass spectra ( Fig. 3) revealed that the stoichiometry of these assemblies is dependent on the size of the OMP client, a result consistent with the kinetic traces described above. Thus, tOmpA and PagP (eight-stranded OMPs) bind only one Skp, whereas the larger OMPs, OmpT, OmpF and tBamA (10-and 16-stranded OMPs), bind up to two copies of Skp. We also observed peaks corresponding to monomeric Skp subunits OmpF is a functional trimer; for clarity, only one subunit is colored, and the other two are shown in gray. Residues missing from chains B and C in the Skp crystal structure were modeled from chain A (green). In b-f, the OM is pale green, and approximate positions of OMPs within the membrane are judged by the position of residues in the 'aromatic girdles' at either side of the membrane 53 . a r t i c l e s (m/z ~2,000) ( Fig. 3) , results indicating either that some dissociation of the assembly occurred in-source and/or reflects the population of monomeric subunits in solution 31, 32 . Interestingly, a 2:1 assembly was the predominant complex observed in the spectrum for the largest 16-stranded OMP studied, tBamA, although the complex was formed by mixture of Skp with tBamA at a 1:1 molar ratio ( Fig. 3f) . We also observed a 2:1 Skp-OMP assembly for full-length BamA (Supplementary Fig. 4 ). To confirm that the Skp/OMP stoichiometry observed through ESI-MS reflected the stoichiometry in solution, we performed chemical cross-linking with bis(sulfosuccinimidyl)suberate (BS3) and subsequent SDS-PAGE analysis of Skp preincubated with full-length OmpA or full-length BamA. In the cross-linked Skp-OmpA samples, we observed a 1:1 assembly ( Supplementary Fig. 5a-d) , whereas in the Skp-BamA samples, we observed a band consistent with a complex with a 2:1 stoichiometry (but no 1:1 Skp-BamA complex) ( Supplementary Fig. 5e-g) .
Insights into Skp-OMP-complex structure from ESI-IMS-MS
We next used ESI-IMS-MS to analyze how Skp binds its OMP clients of larger size. IMS measures the mobility of ions through an inertgas-filled chamber under the influence of a weak electric field, and the drift time (mobility) of an ion in this environment is dependent on the ion's mass, size and charge 28, 33 . Here, we used traveling wave IMS-MS 28, 33 , for which calibration of the measured drift-time data can be performed to obtain rotationally averaged collision cross-sections (CCSs) and consequently gain insight into the conformations of Skp and the Skp-OMP assemblies. We acquired IMS data for all of the assemblies studied ( Fig. 4a-f and Supplementary Fig. 3a-f ) and compared them with known structures, if available, or with models of the Skp-OMP complexes for which there are no high-resolution structural data.
We determined the CCS distributions of the observed ions originating from Skp and 1:1 Skp-OMP complexes, normalized to spectral intensity ( Fig. 4a-f ), and we further plotted the modal CCSs as a function of charge state ( Fig. 4g and Supplementary Table 4 ). Interestingly, the CCSs of the Skp ions ( Fig. 4g) were smaller than expected on the basis of the published Skp crystal structure (in which the modal CCS at the lowest observed charge state, which is least affected by Coulombic repulsion 34 , was 37.9 nm 2 , approximately 25% lower than the expected value of 45.7 nm 2 derived from the crystal structure ( Fig. 4g) ). Molecular dynamics (MD) simulations ( Supplementary Fig. 6 and Supplementary Data Sets 1 and 2) revealed that the assembly collapses in the gas phase, thus resulting in a structure with a CCS of 37.3 ± 1.9 nm 2 (mean ± s.d. of three MD simulations) ( Fig. 4g) .
Binding of Skp to the eight-stranded tOmpA and PagP (Fig. 4g) npg a r t i c l e s comparable to the CCS predicted from the crystal structure of Skp alone (45.7 nm 2 ), thus supporting the notion that these assemblies are specific complexes in which the OMP is located within the central Skp cavity and prevents collapse of the chaperone in the gas phase 15, 16 . Consistently with this possibility, the Skp-OMP complexes sampled a narrower conformational ensemble than did Skp alone, as measured by the width at half height of the mobility peaks observed ( Fig. 4a-c) . Complexation with tOmpA and PagP thus packs the hydrophobic cavity of Skp, resulting in a narrower conformational ensemble consistent with previous data 15 . Interestingly, the 1:1 Skp-OMP assemblies of the larger OMPs studied (OmpT, OmpF and tBamA) ( Fig. 4g ) had larger CCSs (51.4-54.2 nm 2 ) than those of the Skp-tOmpA and Skp-PagP assemblies (~46 nm 2 ). These data, together with the mismatch between the volume of Skp's cavity and the volume likely to be occupied by larger OMP clients in the 'fluid globule' state 15 , suggest that the central cavity expands in size to allow encapsulation of these species, in agreement with recent SANS data 35 . However, our kinetic data ( Fig. 2c,d) indicated that Skp expansion is insufficient to fully sequester these larger OMPs in a 1:1 complex.
Plotting the increase in CCS as a function of molecular weight for Skp and all complexes ( Fig. 4h ), including 2:1 Skp-OMP assemblies ( Supplementary Fig. 3g ), revealed that the data fit to a globular model, irrespective of client size. The complexes exhibited an effective gas phase density of 0.33 Da Å −3 , a value both similar to those reported for other protein complexes 33 and consistent with recent calculations of the CCSs of globular proteins in the Protein Data Bank 36 .
Modeling of larger OMPs in complex with two copies of Skp
We next generated models of the architecture of Skp in complex with OmpT, tBamA or OmpF to determine how Skp and a partially folded Supplementary  Table 3 . Complementary IMS data are shown in Supplementary Figure 3 . Source data for mass spectra are available online. npg a r t i c l e s OMP might interact. We constructed four different models. As a starting point, we modeled encapsulated tOmpA as a sphere with a radius of 20 Å (Fig. 5a ) and a volume of 33,500 Å 3 , values consistent with previous estimates 10, 15 . We assumed that the amino acid density for non-native OMPs bound to Skp is independent of the mass of the OMP studied, in agreement with the MS data presented above. Therefore, to model a 16-stranded OMP, we assumed a spherical volume of ~67,000 Å 3 and hence a radius of ~25 Å, and generated a Skp model with its three subunits surrounding a sphere of this size (Fig. 5b) . The theoretical CCS of the resulting structure (50.4 nm 2 ) ( Fig. 4g ) was in good agreement with the measured CCS values for 1:1 Skp-OmpT, Skp-OmpF and Skp-tBamA complexes (51.4, 51.8 and 54.2 nm 2 , respectively) ( Fig. 4g and Supplementary Table 4 ).
The results therefore suggest that 1:1 Skp-OMP complexes with larger OMPs involve an expanded Skp cavity. Next, we generated models of the 2:1 Skp-OMP complexes, theorizing that Skp might arrange in a side-by-side configuration, in either a parallel or antiparallel arrangement ( Fig. 5c,d) , with the OMP represented by a capsule. We determined the theoretical CCSs of these assemblies to be 79.1 and 78.2 nm 2 , respectively ( Fig. 4g) . Alternatively, we considered a model in which the OMP substrate (represented by a sphere with a radius of ~25 Å) might be encapsulated by two interlocking copies of Skp ( Fig. 5e) , thus resulting in a complex with a theoretical CCS of 73.5 nm 2 (Fig. 4g) . All three values were in good agreement with the measured CCS values for 2:1 Skp-OmpT, Skp-OmpF and Skp-tBamA complexes (71.7, 71.2 and 72.8 nm 2 , respectively) ( Fig. 4g and Supplementary Table 4 ).
Molecular dynamics simulations to model Skp-OMP complexes
To model the Skp-OMP complexes further and aid in their visualization, we performed a series of MD simulations. A simulation of apo-Skp in explicit solvent over 100 ns demonstrated that the individual subunits are highly dynamic and flexible. Each subunit undergoes a transition to an 'open' state, in which subunit helices splay from the central axis, thereby resulting in an expanded central cavity consistent with the results of previous MD studies 18, 35 (Supplementary  Fig. 7a-c Video 1) . The average radius of gyration (R g ) of Skp from the simulation (31.5 Å) was in good agreement with published SANS data (~33 Å) 35 . This R g was ~10% higher than that predicted from the crystal structure, indicating that dynamic motions of the Skp subunits observed in the simulation probably reflect those in solution. In the two Skp crystal structures solved to date 10, 11 , the lower section of one of the subunits is unresolved, thus indicating flexibility, and the angles with which the Skp subunits extend away from the body domain are different for each of the subunits in the two structures 10, 11 . The subunits in the crystal structure of the heterohexameric eukaryotic chaperone prefoldin ( Fig. 5f ) also form different angles with respect to the multimerization domain, which has also been suggested to indicate conformational flexibility that may be functionally relevant 37 .
, Supplementary Data Sets 1 and 3 and Supplementary
Next, we generated models of (8-stranded) tOmpA and (16stranded) tBamA alone in an unfolded, extended conformation and simulated their behavior in solvent (mimicking the situation in which OMPs are diluted from 8 M urea). In each case, the OMPs collapse rapidly into an approximately globular form ( Supplementary  Fig. 7d,e and Supplementary Video 2) . We then generated a model of the 1: (Supplementary Fig. 7b ) and relaxing the resulting structure in vacuo. In the simulation, the subunits of Skp collapse rapidly around the tOmpA substrate, thus resulting in a structure with a CCS value (43.7 ± 1.2 nm 2 ) in excellent agreement with that measured by ESI-IMS-MS (45.6 ± 0.1 nm 2 ); these results suggest that, at least in the gas phase, Skp 'clamps' around the substrate (Fig. 6a,b and Supplementary Video 3) . We created a model for the gas-phase 2:1 Skp-tBamA complex by placing the collapsed tBamA structure in the hydrophobic cavity formed by two copies of Skp in their open conformations. We chose a side-by-side parallel orientation ( Fig. 6c ) on the basis of the striking resemblance of this model to the structure the eukaryotic prefoldin chaperone 37 (Fig. 5f) . The size of the collapsed tBamA model clearly exceeds the maximal dimensions of the cavity of a single Skp observed in an open conformation (Fig. 6c) . Simulation of the 2:1 Skp-tBamA complex in vacuo showed that the Skp subunits also rapidly clamp around the tBamA substrate, thus creating a complex with a CCS of 74.4 ± 1.4 nm 2 , a value again in good agreement with the IMS data (72.8 ± 0.2 nm 2 ) ( Fig. 6d and  Supplementary Video 4) . Thus, the CCS data obtained from both experiment and simulation ( Supplementary Table 5 ) are consistent with a model in which binding of multivalent Skp is necessary to sequester OMPs that exceed the dimensions of the Skp cavity.
To provide evidence that a similar clamping motion of Skp around its OMP substrates could occur in solution, we performed analogous MD simulations of Skp-tOmpA and 2:1 Skp-tBamA complexes in explicit solvent. In these simulations, Skp subunits also wrap around their OMP substrates (Fig. 7a,b and Supplementary Videos 5 and 6), with clamping movements similar to those observed in the gas-phase simulations (Fig. 6) . The complexes formed are stable over 100 ns (Fig. 7c,d) and have larger calculated CCS values (56.5 ± 0.3 nm 2 and 101.2 ± 6.0 nm 2 for Skp-tOmpA and 2:1 Skp-tBamA, respectively) than those after gas-phase simulation (43.7 ± 1.2 nm 2 and 74.4 ± 1.4 nm 2 for Skp-tOmpA and 2:1 Skp-tBamA, respectively). These data are consistent with a model in which the subunits of Skp are dynamic and result in expansion of the hydrophobic cavity, thereby allowing entry of substrates of varying sizes, before the Skp subunits wrap around the sequestered client and protect it from aggregation until client folding into the bilayer can take place.
DISCUSSION
Major advances in the understanding of the cascade of molecular chaperones and folding catalysts involved in OMP biogenesis have been made in recent years, yet the molecular details of how OMPs are bound by molecular chaperones, transported across the periplasm and assembled into the outer membrane, without using the energy of ATP binding and hydrolysis, remain unclear 1, 7, 23 . Here, we provided new insights into how Skp is able to chaperone its broad array of OMP clients, including substrates that are too large to be accommodated within its hydrophobic cavity. We demonstrated that Skp uses subunit dynamics to expand the size of its client-binding cavity and that Skp functions as a multivalent chaperone that sequesters and prevents aggregation of its larger OMP clients. Further, we used ESI-IMS-MS to gain structural insight into the 1:1 and 2:1 Skp-OMP complexes that we identified. Using kinetic refolding and ESI-IMS-MS data combined with MD simulations, we generated models consistent with the experimental results in which Skp sequesters larger OMPs by binding in a multivalent arrangement (side-by-side parallel or antiparallel, and/or via an interlocking structure) ( Fig. 5c-e) . The parallel side-by-side model (Fig. 5c ) bears a striking resemblance to the structure of the nonhomologous chaperone prefoldin 37 (Fig. 5f) . Resolving the precise orientations of Skp molecules in these multivalent complexes will require more information, for example from cross-linking experiments followed by MS/MS. Nonetheless, our biochemical, MS and MD results indicate that the ability of Skp to chaperone OMPs ranging from 35 to 43 kDa in size requires both subunit dynamics and Skp's ability to function as a multivalent chaperone.
Skp has been shown in vivo to interact with much larger substrates than those investigated here (19-43 kDa), including BtuB (66 kDa), FhuA (79 kDa) and LptD (87 kDa) which form β-barrels composed of 22, 22 and 26 β-strands, respectively 12, 38 . It is likely these proteins also form multivalent complexes with Skp, and indeed recent data on the interaction between Skp and FhuA are consistent with a Skp/OMP stoichiometry greater than 1:1 (ref. 39) .
The present results have implications for the understanding of how OMPs are chaperoned by Skp in the periplasm, including the mechanisms of substrate binding and release. Our atomistic MD trajectories of apo-Skp showed that it exists in a wide range of open conformations and exhibits large differences in the area of the cavity entrance formed between the tips of its three subunits. Such conformational flexibility has been implicated in the mechanisms of other ATP-independent chaperones 40, 41 . We propose that in rescuing aggregation-prone proteins 6 , Skp may be thought of as being analogous to a pair of 'calipers' that samples open conformations before client capture and consequently adjusts the volume of its central cavity. In this model, once the substrate has entered the Skp cavity, the Skp subunits clamp down and protect the exposed hydrophobic surfaces of the protein, in a mechanism similar to those of other chaperones such as trigger factor or Hsp90 (ref. 42) . For substrates too large to be accommodated within the Skp substrate cavity, additional copies of Skp recognize and engulf sections of the substrate not already encapsulated. In vivo cross-linking evidence has suggested npg a r t i c l e s that Skp can interact with OMPs as they emerge from the SecYEG translocon 43 . Thus, it is possible that during translocation of larger OMPs, the substrate is fed directly into the cavity of Skp, and the chaperone's maximum binding capacity might be reached before the complete polypeptide chain is translocated. Subsequent polypeptide chain emerging from the translocon could then be bound by a second or more Skps, thereby ensuring sequestration of the entire polypeptide sequence so that periplasmic aggregation is prevented.
Recent equilibrium sedimentation experiments of Skp in the absence of substrate have demonstrated a dynamic equilibrium between folded subunit monomers and trimers at physiological concentrations 32 . Therefore, a possible alternative in vivo pathway to the formation of Skp-OMP complexes may involve sequential binding of monomer subunits to OMP substrates, such that Skp trimerization is linked to (and indeed driven by) substrate binding. Sandlin et al. have raised the possibility that more diverse species of Skp might form around an unfolded OMP 32 . However, for the complexes studied here, we observed only Skp-OMP complexes containing monomeric Skp subunits in multiples of three ( Fig. 3) , thus suggesting either that the trimeric unit is the OMP-binding species or that complexes of other composition are unstable in the gas phase.
It has been proposed that transient exposure of the C-terminal OMP-targeting sequence (β-signal) 44, 45 , and its recognition by the BAM complex 46 , triggers substrate release from Skp 15 . The space between Skp subunits (~25 Å in the crystal stucture 10 ) and/or the inherent dynamics of the complex may facilitate the transient solvent exposure of regions of the OMP substrate, thus permitting β-signal recognition. Consistently with this possibility, the presence of BamA in liposomes has been found to relieve the folding inhibition of OmpA by Skp in vitro 47 . Interestingly, all 2:1 Skp-OMP models proposed here retain a substantial distance (>20 Å) between the Skp subunits, and this distance would permit exposure of sections of the substrate polypeptide required for BAM signaling and/or membrane insertion. The release of the OMP from Skp is likely to be driven by the increased thermodynamic stability of the folded OMP relative to the chaperone-bound state 48 , and, for OMPs bound to more than one Skp, it is possible that individual copies of Skp might be released sequentially in a process driven by the free energy of OMP folding.
Chaperones utilize two general strategies to protect substrates from misfolding and aggregation. In the first, substrates are chaperoned by sequential binding and release of exposed hydrophobic surfaces along an extended polypeptide chain. This 'beads on a string' model is typified by chaperones such as the Hsp70s and trigger factor 8, 49 . Alternatively, aberrant interactions may be prevented by sequestration of the substrate from the cellular environment within an enclosed space, as is the case for the 'cage-like' chaperonins such as GroEL and GroES, and TriC 8, 49 . The data presented here suggest that Skp operates with a 'hybrid' mechanism, using both of these strategies to bind and encapsulate its OMP clients, thereby preventing their aggregation and facilitating their delivery to the OM, where folding can successfully occur.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ACkNoWlEDgmENtS
The plasmids containing the mature sequences of tOmpA, PagP, OmpA and BamA were kindly provided by K. Fleming (John Hopkins University) 25 . Plasmid pET21b (Novagen) containing the Skp-encoding gene was a gift from J. Bardwell (University of Michigan). We also thank S. Hiller (University of Basel) for kindly providing the His-tagged Skp construct 15 a r t i c l e s ONLINE METHODS Cloning of OmpF, tBamA and OmpT. A codon-optimized synthetic gene (Eurofins) of the mature sequence of OmpF (residues 23-362) was cloned into pET11a (Novagen) between the NdeI (5′) and BamHI (3′) restriction sites. To create the tBamA construct, residues 425-810 of BamA were amplified by PCR, with plasmid BamAB-pETDUET-1 (kindly donated by S. Buchanan (NIH)) as the template, and the resultant product was then ligated into pET11a as described above. The OmpT mature sequence (residues 21-217) was amplified by PCR from E. coli XL1-blue cells to include an N-terminal His 6 tag and TEV protease-cleavage site (MH 6 ENLYFQG-OmpT), and was subsequently cloned into the pET11a vector as described above. The plasmids for tOmpA, PagP, OmpA and BamA encoding the mature OMP sequences were kindly provided by K. Fleming (John Hopkins University) 25 .
Expression and purification of PagP, tOmpA, OmpF, tBamA, OmpA and BamA. The relevant plasmid was transformed into BL21(DE3) cells (Stratagene), and the appropriate OMP was expressed and purified as previously described 27 . Protein concentrations were determined spectrophotometrically by using molar extinction coefficients at 280 nm of 82,390, 46,870, 54,210, 101,315, 52,955 and 140,040 M −1 cm −1 for PagP, tOmpA, OmpF, tBamA, OmpA and BamA, respectively.
Expression and purification of OmpT. Expression and purification of
OmpT was carried out as previously described 54 . The protein concentration was determined spectrophotometrically by using a molar extinction coefficient at 280 nm of 79,760 M −1 cm −1 .
Expression and purification of Skp. The pET21b plasmid, containing the fulllength Skp gene, including the N-terminal signal sequence, was transformed into BL21(DE3) cells (Stratagene). Cells were grown in LB medium containing 100 µg/mL carbenicillin at 27 °C with shaking (200 r.p.m.) until the culture reached an OD 600 of ~0.6 (after ~6 h). Cultures were induced with 25 µM IPTG, expressed overnight and harvested by continuous centrifugation at 15,000 r.p.m. (Heraeus Contifuge, rotor 8575, Thermo Fisher Scientific). The cell pellet was resuspended in 50 mM Tris-HCl, 5 mM EDTA and 50 mM NaCl, pH 7.5, at 4 °C with gentle agitation for ~48 h. 1 mg/mL polymyxin B sulfate was added to the resuspended cells, and the cells were then incubated for 1 h at 4 °C with gentle agitation. Spheroplasts were sedimented by centrifugation (12,000g, 20 min, 4 °C), and the supernatant was dialyzed against 20 mM Tris-HCl and 100 mM NaCl, pH 8.0 (buffer A) overnight at 4 °C. The periplasmic extract was filtered (0.4-µm syringe filter, Sartorius) and loaded onto a HiTrapQ (5-mL) anionexchange column (GE Healthcare). The flow through from this column was loaded onto a HiTrap SP (5-mL) cation-exchange column (GE Healthcare) equilibrated with buffer A. The column was washed with five column volumes of buffer A and eluted with a gradient (0-100%) of 20 mM Tris-HCl and 750 mM NaCl, pH 8.0 (buffer B). Peak fractions were dialyzed against 20 mM Tris-HCl, pH 8.0, and concentrated to ~50 µM (trimer) with Vivaspin 20 concentrators (Sartorius; 5-kDa MWCO). Aliquots were snap-frozen in liquid nitrogen and stored at −80 °C. Protein concentrations were determined with bicinchoninic acid (BCA) assays (Thermo Fisher Scientific), according to the manufacturer's instructions.
Expression and purification of histidine-tagged Skp. Histidine-tagged Skp was expressed and purified with a protocol adapted from Burmann et al. 15 . The pET28b plasmid, containing the Skp-encoding gene with an N-terminal His 6 tag and thrombin-cleavage site, was transformed into BL21(DE3)pLysS cells (Stratagene). Cells were grown in LB medium containing 30 µg/mL kanamycin at 37 °C with shaking (200 r.p.m.) until the culture reached an OD 600 of ~0.6. The temperature was then lowered to 20 °C, and expression was induced with 0. Fractions containing Skp were pooled, and the protein was refolded by dialysis against 25 mM Tris-HCl, pH 7.2, and 150 mM NaCl. Refolded histidine-tagged Skp was concentrated to ~50 µM (trimer) with Vivaspin 20 concentrators (Sartorius; 5-kDa MWCO), divided into aliquots, snap-frozen in liquid nitrogen and stored at −80 °C. Protein concentrations were determined with BCA assays (Thermo Fisher Scientific), according to the manufacturer's instructions.
Preparation of liposomes. 1,2-diundecanoyl-sn-glycero-3-phosphocholine (diC 11:0 PC or DUPC) lipids were purchased from Avanti Polar Lipids. DUPC was obtained as a powder, dissolved in a 80:20 chloroform/methanol mixture at 25 mg/mL and stored at −20 °C until use. Appropriate volumes were transferred to glass test tubes, and an even lipid film was created by drying under a gentle stream of nitrogen during moderate shaking in a 42 °C water bath. Lipid films were further dried in a vacuum desiccator for >3 h and then resuspended in 50 mM glycine-NaOH, pH 9.5, to a concentration of 40 mM. Resuspended lipids were vortexed briefly and allowed to stand for 30 min. After being vortexed again, lipids were subjected to five freeze-thaw cycles with liquid nitrogen. Large unilamellar vesicles (LUVs) (100 nm) were prepared by extrusion of the lipid suspension 11 times through a 0.1-µm polycarbonate membrane (Nuclepore) with a mini extruder (Avanti Polar Lipids). Liposomes were stored at 4 °C and used within 48 h of preparation.
Kinetic folding assays. Kinetic measurements were carried out with a Quantum Master Fluorimeter (Photon Technology) controlled by FelixGX software v4.3. For each experiment, four separate samples were run in a four-cell changer maintained at 25 °C by a Peltier controlled temperature unit. The tryptophan fluorescence of samples was excited at a wavelength of 295 nm, and fluorescence emission was monitored at 335 nm. 295 nm rather than 280 nm was chosen as the excitation wavelength to minimize the fluorescence-intensity contribution from Skp, which contains tyrosine but no tryptophan residues. The excitation slit widths were set to 0.4-0.6 nm, and the emission slit widths were set to 5 nm. The high emission/ excitation slit-width ratio was important to minimize photobleaching on the experi- The final volume of each sample was 500 µL. For Skp-OMP experiments, OMPs were preincubated with Skp for approximately 1 min before addition of liposomes. OMPs were diluted and mixed from an 80 µM stock in 8 M urea to a final concentration of 2.4 µM, in the presence of the appropriate molar ratio of Skp, in 0.24 M urea and 50 mM glycine-NaOH, pH 9.5 (no lipids). This Skp-OMP stock was then further diluted 6× in the presence of 1.28 mM DUPC in 0.24 M urea and 50 mM glycine-NaOH, pH 9.5, to begin the assay. The final volume of each sample was 540 µL. At the concentrations of Skp used here, Skp has been shown to be in a dynamic equilibrium between folded monomer subunits and trimers 32 . All Skp concentrations referred to here are trimer equivalents. For each experiment with a particular liposome batch, four samples were measured concurrently. A minimum of three replicates were globally fitted with IgorPro 6.0 (Wavemetrics) to extract rate constants, and the fits were forced to share the same rate constants. Transients were fitted either to a single-exponential function: where k 1 and k 2 are rate constants, A 1 and A 2 are their associated amplitudes, and c is a constant. Transients were fitted to a double-exponential function if a satisfactory fit was not obtained to a single-exponential function, as judged by inspection of residuals. Experiments were performed for each condition with three separate liposome batches, and reported errors are the s.d. of rate constants among liposome batches.
npg Fluorescence emission spectra. Fluorescence emission spectra were acquired on the same instrument used for the kinetic assays (above). Each spectrum was recorded from 305 nm to 400 nm in 1-nm increments, with an excitation wavelength of 295 nm. All spectra were acquired at 25 Theoretical CCSs for globular proteins with a given effective gas phase density were calculated according to previously described methods 57 .
Chemical cross-linking and SDS-PAGE analysis. Samples for chemical crosslinking were prepared by rapid dilution of urea-denatured OMP into a Skp solution (in 20 mM HEPES, pH 7.5, and 150 mM NaCl) at 4 °C, so that the final concentrations of Skp and OMPs were 20 µM in a final concentration of 0.24 M urea. Samples were mixed for 2 min and centrifuged (20 min, 13,000g, 4 °C) to remove aggregated material. The supernatant was removed, and BS3 (Thermo Scientific) was added at a 50-fold molar excess over the Skp concentration. Samples were incubated at room temperature for 30 min before the addition of 250 mM glycine, pH 9.5. Samples were analyzed through SDS-PAGE, and the gels were stained with Coomassie blue (InstantBlue, Expedeon), or the proteins were transferred to a PVDF membrane and immunoblotted with an anti-histidine HRP-conjugated antibody (cat. no. 15165, Thermo Scientific; validation on manufacturer's website). Gel bands were excised, cut into 1 mm 3 pieces, destained with 30% ethanol and washed with 50% acetonitrile in 25 mM ammonium bicarbonate (10 min). The gel pieces were then dehydrated with acetonitrile (5 min), and the residual volatile solvent was removed by evaporation. The pieces were then rehydrated with a solution of trypsin (Promega) (20 ng µL −1 in 25 mM ammonium bicarbonate) and incubated at 37 °C for 18 h. Peptides were recovered by three rounds of addition, incubation and removal of 60% acetonitrile/5% formic acid to the gel pieces. The samples were then pooled and concentrated.
Peptides were analyzed through data-dependent LC-MS/MS on a nanoAcquity LC system interfaced with a Synapt G2-Si HDMS mass spectrometer (Waters). Peptides (1 µL) were injected onto an Acquity M-Class C18, 75 µm × 150 mm column (Waters) and then separated by gradient elution of 1-50% solvent B (0.1% (v/v) formic acid in acetonitrile) in solvent A (0.1% (v/v) formic acid in water) over 60 min at 0.3 µL min −1 . Mass calibration was performed through a separate injection of aqueous sodium iodide at a concentration of 2 µg/µl.
[Glu1]-fibrinopeptide B was infused as a lock mass calibrant. Data acquisition was achieved through data-dependent analysis with a 1-s MS scan over an m/z range of 350-2,000, and this was followed by four 0.5-s MS/MS scans of the four most intense ions in the MS spectrum. Data processing was performed with PEAKS Studio 7 (Bioinformatics Solutions).
Modeling of Skp-OMP complexes.
All modeling was performed with PyMOL (http://www.pymol.org/). To generate models of the Skp-OMP complexes, the missing residues in chains B and C of the Skp crystal structure (PDB 1U2M 10 ) were modeled from chain A. For the Skp-tOmpA/PagP model (Fig. 5a) , the OMP was modeled as a sphere of radius 20 Å with its origin positioned at the geometric center between the α-carbon atoms of residue 50 of each Skp chain. For the Skp-OMP model with expanded Skp subunits (Fig. 5b) , each chain was positioned around a sphere of radius 25 Å representing the larger OMP. The flexible tips of each subunit (residues 51-101) were modeled hinged slightly inward to wrap around the substrate. The side-by-side parallel and antiparallel 2:1 Skp-OMP models (Fig. 5c,d) were created by duplication of the Skp-tOmpA/PagP model ( Fig. 5a) and appropriate rotation and translation. The interlocking-trimer 2:1 Skp-OMP model (Fig. 5e) was generated by duplication of the Skp model with an expanded cavity ( Fig. 5b) and appropriate rotation and translation of the duplicated Skp. Theoretical CCS values were generated by using the calibrated trajectory method implemented in IMPACT 36 .
Molecular dynamics simulations. MD simulations were prepared with the AmberTools 14 suite of programs and performed with AMBER and the ff14SB force field 58 . To simulate apo-Skp in water, a Skp model was first generated from the Skp crystal structure (PDB 1U2M 10 ) with the residues absent in chains B and C modeled from chain A. After addition of hydrogen atoms with xleap, Skp was placed in a TIP3P water box with a 10.0-Å cutoff, and the system was neutralized with a total of 15 Cl − ions. The system was equilibrated through an initial energy minimization, which was followed by 80 ps of restrained MD during which the system was heated to 300 K with gradual releasing of restraints. An unrestrained MD simulation of 100 ns was then performed.
Simulations of the collapse of the extended chains of tOmpA and tBamA were carried out with a generalized Born/solvent accessible surface area (GB/SA) implicit solvent model 59, 60 . Use of an implicit solvent model speeds up the exploration of conformational space by at least an order of magnitude because of the neglect of frictional forces from collisions with water molecules 61 , thereby leading to rapid adoption of a collapsed configuration from the initially linear structure (Supplementary Fig. 7d,e and Supplementary Video 2) . The polypeptide starting structures were generated in xleap and, after initial energy minimization, were simulated for 3 ns. The starting models for the simulation of Skp-tOmpA and Skp 2 -tBamA in vacuo were created in PyMOL by positioning OMPs, after simulated collapse, within the cavity of Skp-trimer structures in an open conformation taken from the explicit solvent apo-Skp simulation. All simulations except apo-Skp in explicit water were performed in triplicate. Each in vacuo simulation of Skp-tOmpA and 2:1 Skp-tBamA was performed with a starting OMP structure from a different simulation. In vacuo simulations of apo-Skp were performed for three different starting structures selected from the simulation of apo-Skp in explicit water. For all in vacuo simulations, the system was equilibrated with an initial energy minimization, and this was followed by eight steps of restrained MD during which the system was heated to 300 K with gradual releasing of restraints. Subsequently, an unrestrained MD simulation of 100 ns was performed.
To simulate the 1:1 Skp-tOmpA and 2:1 Skp-tBamA complexes in solution, starting models were generated as detailed above for the in vacuo simulations. The Skp-OMP complexes were placed in a TIP3P water box with a 10.0-Å cutoff, and the system was neutralized with a total of 10 Cl − ions (1:1 Skp-tOmpA) or 12 Cl − ions (2:1 Skp-tBamA). The systems were equilibrated with an initial energy minimization, and this was followed by 80 ps of restrained MD during which the system was heated to 300 K with gradual releasing of restraints. Subsequently, an unrestrained MD simulation of 100 ns was performed. For each complex, simulations were repeated in triplicate.
For comparison with IMS-MS data, theoretical CCSs of final structures at the ends of simulations were calculated with the trajectory method and IMPACT 36 . CCS values for all structures after in vacuo simulations were obtained after 100 ns of unrestrained simulation. CCS values for tOmpA and tBamA in implicit solvent were obtained after 3 ns of unrestrained simulation. The integration time step was 2 fs, and atomic positions were saved every 500 steps (1 ps). VMD software was used to compute backbone r.m.s. deviations and to render videos of the simulations. Analyses of R g changes over trajectories were carried out with ptraj.
